Interesting.
A new ovarian cell creation process is developed by this Japanese company Dioseve and they can skip clinical trials because the product is not considered a medicine.
This new technology can reduce more than 80% of hormone injection in an IVF process.
Link to exact point of that conversation.
https://pca.st/episode/27b147a5-1d4e-4ed5-8464-a44b07279b69?t=1179.0